Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Cardiff Oncology, Inc. Director's Dealing 2021

Jul 13, 2021

33967_dirs_2021-07-13_46fd7acf-c3e4-4deb-8bfe-1b13b305db9f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cardiff Oncology, Inc. (CRDF)
CIK: 0001213037
Period of Report: 2021-07-06

Reporting Person: Ruffner Katherine L (Chief Medical Officer)

More from Cardiff Oncology, Inc.

Regulatory Filings 2026
May 29
Regulatory Filings 2026
May 19
Regulatory Filings 2026
May 14
Interim / Quarterly Report 2026
May 14
Regulatory Filings 2026
Apr 9
Regulatory Filings 2026
Feb 25
Regulatory Filings 2026
Feb 24
Annual Report 2026
Feb 24
Director's Dealing 2026
Feb 18
Director's Dealing 2026
Feb 18
View all filings →